Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Change in Account Payables (2020 - 2026)

Nuvalent's (NUVL) quarterly Change in Account Payables came in at -$7.7 million in Q1 2026, down 136.71% YoY from $20.9 million in Q1 2025, and down 198.39% on a QoQ basis from $7.8 million in Q4 2025.

Analysis

Nuvalent (NUVL) Change in Account Payables (2020 - 2026) Analysis & Trends

Nuvalent (NUVL) has 7 years of Change in Account Payables data on file, last reported at -$7.7 million in Q1 2026.

  • Quarterly Change in Account Payables fell 136.71% year-over-year to -$7.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.0 million (down 131.55% YoY) and the FY2025 annual result came in at $24.6 million, up 707.53% from the prior year.
  • Change in Account Payables slipped to -$7.7 million in Q1 2026, from $7.8 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $20.9 million in Q1 2025 to a low of -$12.8 million in Q2 2025.
  • A 5-year average of $1.1 million and a median of $1.4 million in 2022 frame the typical range for Change in Account Payables.
  • Annual changes were most pronounced in 2023 — Change in Account Payables jumped 872.48% — and 2024, when it slumped 1996.45%.
  • Tracing NUVL's Change in Account Payables over 5 years: stood at $2.5 million in 2022, then tumbled by 120.4% to -$507000.0 in 2023, then tumbled by 1996.45% to -$10.6 million in 2024, then soared by 173.52% to $7.8 million in 2025, then tumbled by 198.39% to -$7.7 million in 2026.
  • The last three Change in Account Payables figures came in at -$7.7 million (Q1 2026), $7.8 million (Q4 2025), and $8.7 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Nuvalent 9.75 Bn 9.75 Bn - -7.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -7.69 Mn
Dec 31, 2025 7.81 Mn
Sep 30, 2025 8.67 Mn
Jun 30, 2025 -12.82 Mn
Mar 31, 2025 20.94 Mn
Dec 31, 2024 -10.63 Mn
Sep 30, 2024 8.45 Mn
Jun 30, 2024 -5.99 Mn
Mar 31, 2024 4.12 Mn
Dec 31, 2023 -507,000.00
Sep 30, 2023 1.66 Mn
Jun 30, 2023 1.68 Mn
Mar 31, 2023 -672,000.00
Dec 31, 2022 2.49 Mn
Sep 30, 2022 592,000.00
Jun 30, 2022 -218,000.00
Mar 31, 2022 1.35 Mn
Dec 31, 2021 732,000.00
Sep 30, 2021 -914,000.00
Jun 30, 2021 1.63 Mn